A 12 months comparison of the efficacy and safety of formoterol 4.5 mcg as needed with terbutaline 0.5 mg as needed in patients with asthma not treated with IGCS.
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
No locations available